Abstract
We previously demonstrated that bone marrow (BM) cells migrate to Ewing’s tumors and differentiate into endothelial cells within the tumor vasculature. Recent evidence suggests that the roles of BM cells in tumors are more diverse. We investigated whether non-endothelial cell types critical for tumor vessel development are also derived from migrated BM cells. We utilized BM transplantation with GFP+ transgenic mice as BM donors and nude mice as recipients to track the fate of migrated BM cells. After engraftment, we injected recipient mice either subcutaneously or intramuscularly with Ewing’s sarcoma cells. We labeled functional tumor vessels using intravascular perfusion staining with tomato lectin. We assessed BM cell recruitment/differentiation within the tumor microenvironment using immunohistochemistry. Ewing’s tumors contained BM-derived cells that had differentiated into endothelial cells lining perfused tumor vessels. A substantial fraction of recruited BM cells also resided in the vessel vicinity and expressed desmin and PDGFR-β, indicating smooth muscle cell differentiation. In order to further characterize the role of stem/progenitor cells in Ewing’s sarcoma, we sorted Tie2− BM cells from Tie2-GFP transgenic mice and then injected them intravenously into Ewing’s tumor-bearing mice. Tie2− BM progenitors migrated to Ewing’s tumors and differentiated into Tie2+ cells occupying a perivascular residence and expressing α-smooth muscle actin, desmin and PDGFR-β, as well as VEGFR-2. We did not observe differentiation of Tie2− cells into Tie2+ perivascular cells in VEGF165-inhibited TC/siVEGF7-1 tumors. The differentiation of Tie2− BM cells into Tie2+ cells in parental but not VEGF165-inhibited tumors indicates that the tumor microenvironment may influence the differentiation pathway.
Similar content being viewed by others
Abbreviations
- BM:
-
Bone marrow
- GFP:
-
Green fluorescent protein
- IHC:
-
Immunohistochemistry
- PDGFR-β:
-
Platelet-derived growth factor receptor-β
- TC/siVEGF7-1 :
-
VEGF165 small interfering RNA (siRNA)-inhibited clone
- VEGFR-2:
-
Vascular endothelial growth factor receptor-2
References
Bolontrade MF, Zhou RR, Kleinerman ES (2002) Vasculogenesis plays a role in the growth of Ewing’s sarcoma in vivo. Clin Cancer Res 8:3622–3627
Lee TH, Bolontrade MF, Worth LL, Guan H, Ellis LM, Kleinerman ES (2006) Production of VEGF165 by Ewing’s sarcoma cells induces vasculogenesis and the incorporation of CD34+ stem cells into the expanding tumor vasculature. Int J Cancer 119:839–846
Guan H, Zhou Z, Wang H, Jia S-F, Liu W, Kleinerman ES (2005) A small interfering RNA targeting vascular endothelial growth factor inhibits Ewing’s sarcoma growth in a xenograft mouse model. Clin Cancer Res 11:2662–2669
Lyden D, Hattori K, Dias S, Costa C, Blaikie P, Butros L, Chadburn A, Heissig B, Marks W, Witte L, Wu Y, Hicklin D (2001) Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 7:1194–1201
Dwenger A, Rosenthal F, Machein M, Waller C, Spyridonidis A (2004) Transplanted bone marrow cells preferentially home to the vessels of in situ generated murine tumors rather than of normal organs. Stem Cells 22:86–92
Duda DG, Cohen KS, Kozin SV, Perentes JY, Fukumura D, Scadden DT, Jain RK (2006) Evidence for incorporation of bone marrow-derived endothelial cells into perfused blood vessels in tumors. Blood 107:2774–2776
Song S, Ewald AJ, Stallcup W, Werb Z, Bergers G (2005) PDGFRβ+ perivascular progenitor cells in tumors regulate pericyte differentiation and vascular survival. Nat Cell Biol 7:870–879
Rajantie I, Ilmonen M, Alminaite A, Ozerdem U, Alitalo K, Salven P (2004) Adult bone marrow-derived cells recruited during angiogenesis comprise precursors for periendothelial vascular mural cells. Blood 104:2084–2086
Lamagna C, Bergers G (2006) The bone marrow constitutes a reservoir of pericyte progenitors. J Leukoc Biol 80:677–681
De Palma M, Venneri MA, Roca C, Naldini L (2003) Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells. Nat Med 9:789–795
Yang L, DeBusk LM, Fukuda K, Fingleton B, Green-Jarvis B, Shyr Y, Matrisian LM, Carbone DP, Lin PC (2004) Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis. Cancer Cell 6:409–421
Yotnda P, Onishi H, Heslop HE, Shayakhmetov D, Lieber A, Brenner M, Davis A (2001) Efficient infection of primitive hematopoietic stem cells by modified adenovirus. Gene Ther 8:930–937
Hellstrom M, Kalen M, Lindahl P, Abramsson A, Betsholtz C (1999) Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 126:3047–3055
Lindahl P, Johansson BR, Leveen P, Betsholtz C (1997) Pericyte loss, microaneurysm formation in PDGF-B-deficient mice. Science 277:242–245
Bergers G, Song S, Meyer-Morse N, Bergsland E, Hanahan D (2003) Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J Clin Invest 111:1287–1295
De Palma M, Venneri MA, Galli R, Sergi Sergi L, Politi LS, Sampaolesi M, Naldini L (2005) Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 8:211–226
Acknowledgments
Grant sponsors: NIH, Grant number: R01 CA103986 (ESK), Core Grant CA 16672.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Reddy, K., Cao, Y., Zhou, Z. et al. VEGF165 expression in the tumor microenvironment influences the differentiation of bone marrow-derived pericytes that contribute to the Ewing’s sarcoma vasculature. Angiogenesis 11, 257–267 (2008). https://doi.org/10.1007/s10456-008-9109-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10456-008-9109-1